UDG Healthcare agrees £2.6bn private equity offer
The FTSE 250 group has also posted its interim results and announced the acquisition of US-based consultancy Nuvera
UDG Healthcare PLC (LON:UDG) announced it is recommending a £2.6bn cash offer put forward by private equity firm Clayton, Dubilier & Rice.
Under the terms of the acquisition, shareholders will receive 1,023p per share, which is a premium of 21.5% on Tuesday’s closing price.
The board of directors unanimously voted in favour and recommend shareholders to approve the deal, the healthcare services provider said.
“While the UDG board remains confident in the long term fundamentals of the group, we believe that this is an attractive offer for UDG shareholders, which secures the delivery of future value for shareholders in cash today,” said the firm’s chairman Shane Cooke.